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and had been diagnosed with normocytic anemia.At that time, she
received treatment with an iron preparation because of a low
serum iron level despite her normal ferritin level. We estimate that
the patient already had mild alveolar hemorrhage at that time and
the bleeding later healed spontaneously. Among the cases of this
disease reported from Japan, the disease tended to develop more
frequently in the spring. In our patient, the disease developed twice
(both times in June), suggesting the possibility that infection
triggered the disease onset. Although alveolar hemorrhage sub-
sided spontaneously in this case, lung fibrosis may develop in the
future if alveolar bleeding develops repeatedly and its diagnosis is
delayed. In the present case, treatment was started immediately
after diagnosis and rapid aggravation of her renal function was
prevented. When dealing with cases in whom unexplained nor-
mocytic anemia repeatedly occurs or cases with a discrepancy
between serum iron and ferritin levels, the possibility of intrapul-
monary bleeding should be considered and a chest X-ray should be
obtained. Incidentally, after the diagnosis of this case was estab-
lished, we inquired at the other hospital regarding the rapidly
progressive glomerulonephritis of her younger sister and were
informed that the disease was also confirmed to beANCA-positive
microscopic polyangiitis, identical to her elder sister’s disease.
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Abstract Acute lymphoblastic leukemia with eosinophilia (ALLEo) is a rare but a distinctive clinical entity. Clinical features of
idiopathic hyper-eosinophilic syndrome (HES) can be seen in patients with ALLEo. We report a 10-year-old girl, in
whom HES was initially suspected but further investigation confirmed the diagnosis of acute B-cell lymphoblastic
leukemia with myeloid antigen expression. Clinical response to chemotherapy was excellent with achievement of
complete remission for 4 years. Serum interleukin-3 and -5 were elevated at presentation and normalized with disap-
pearance of eosinophilia after induction therapy, supporting the reactive nature of eosinophilia in ALLEo. Hematologic
malignancy should be considered in patients with hyper-eosinophilia, before attributing it to HES.
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Acute lymphoblastic leukemia with eosinophilia (ALLEo) is a
rare but distinctive clinical entity. There have been approximately
50 cases of ALLEo reported.1–4 Patients with ALLEo can present
with clinical features of idiopathic hyper-eosinophilic syndrome
(HES) due to eosinophilic organ infiltration. Bone marrow analy-
sis is important for investigating the etiology of eosinophilia even
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without blasts in peripheral blood smear or cytopenia.5 Further
diagnostic investigations to exclude different types of hemato-
logic malignancy are important before attributing peripheral
blood eosinophilia to HES.6 Herein we describe the case of a
10-year-old girl with acute B-cell lymphoblastic leukemia with
myeloid antigen expression, in whom cytokine production in the
lymphoblasts was investigated.
Case report
A 10-year-old girl developed pruritic, erythematous rash on her
extremities, 6 months prior to presentation. One month prior to
presentation, she had persistent skin rash and headache with an
absolute eosinophil count of 8.93 ¥ 109/L. She was then admitted
to the National Defense Medical College hospital because of
arthralgia in both wrists, swelling of right shoulder, and shortness
of breath with exertion. Her past and family history was unre-
markable. On admission her vital signs were within normal
limits, with normal cardiopulmonary examination. On complete
blood count the white blood cells (WBC) were 12.6 ¥ 109/L,
hemoglobin was 12.0 g/dL, and the platelets were 177 ¥ 109/L
with differential of neutrophilic bands (35%), neutrophilic seg-
mentals (9%), lymphocytes (15%), and eosinophils (39%). There
were no blasts on the peripheral blood smear. Eosinophils were
hyperlobulated with decreased cytoplasmic granules (Fig. 1a).
We investigated the etiology of eosinophilia and found
elevated C-reactive protein of 3.5 mg/dL and erythrocyte sedi-
mentation rate of 50 mm/h. Soluble interleukin-2 (IL-2) receptor
was elevated at 4450 U/mL. Ova and parasite study of stool was
negative. Chest radiography and computed tomography of the
chest showed diffuse infiltrates in both lungs. The pulmonary
function test showed a restrictive pattern. Echocardiography
showed good biventricular function. We suspected HES, because
the patient had multiple organ involvement with significant
eosinophilia.
Bone marrow aspiration was performed to exclude hemato-
logic malignancy and indicated hypercellular marrow with lym-
phoblasts 90% and eosinophils 2%. Lymphoblasts were L1 in the
French–American–British classification and were negative on
myeloperoxidase and periodic acid–Schiff stain (Fig. 1b).
Cytoplasmic granules of lymphoblasts were positive for a-
naphthyl-butyrate esterase without NaF inhibition (Fig. 1c).
Immunophenotyping on bone marrow CD45 dim cells showed
lymphoblastic B-lineage cells expressing CD10, CD19, CD20,
CD22, CD34, CD38, and the myeloid antigen CD33; this con-
firmed the diagnosis of acute precursor B-cell lymphoblastic
leukemia. Cytogenetic analysis indicated normal karyotype
46,XX. Cerebrospinal fluid was negative for leukemia (1 WBC, 0
red blood cells, no blasts). The patient was enrolled in the Chil-
dren’s Cancer and Leukemia Study Group protocol ALL2004
(high-risk arm). Induction chemotherapy was initiated with adria-
mycin, vincristine, prednisone, and l-asparginase. Her symptoms,
pulmonary infiltrates, and eosinophilia resolved quickly with
induction chemotherapy, and the patient has remained in complete
remission for 4 years since the onset of the disease.
We measured levels of IL-3, IL-5, and granulocyte
macrophage–colony-stimulating factor (GM-CSF) in serum,
Fig. 1 Pathology on admission. (a) Eosinophils on peripheral blood
smear. Eosinophils were hyperlobulated with decreased cytoplasmic
granules. (b) Lymphoblasts in bone marrow. Wright-Giemsa stain.
(c) Lymphoblasts in bone marrow. Cytoplasmic granules positive for
a-naphthyl-butyrate esterase stain. Granules were not inhibited
by NaF.
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using an ELISA kit (IL-3, GM-CSF: R&D Systems, Minneapo-
lis, MN, USA; IL-5: Immunotech, Marseille, France). IL-3 and
IL-5 in serum were elevated on admission, and normalized
after induction therapy (Table 1). We assayed the expression of
Fip1-like1-platelet-derived growth factor receptor alpha
(FIP1L1-PDGFRA) mRNA on reverse transcriptase–polymerase
chain reaction (RT-PCR) using the lymphoblasts in bone marrow,
as previously described.7 RT-PCR of FIP1L1-PDFGRA mRNA
was not detected in this case.
Discussion
Acute lymphoblastic leukemia with eosinophilia occurs rarely
and 52 cases of ALLEo have been reported in 44 studies.7,8 A
review of 38 cases of ALLEo reported male predominance
(76%), a median age of 14 years, and a median absolute eosino-
phil count at presentation of 10.78 ¥ 109/L as well as clinical
presentation such as splenomegaly (60%), skin rash (54%),
cough or dyspnea (43%), pneumonia or pulmonary infiltrates
(51%), chest pain (20%), and adenopathy (46%).2 Skin findings
reported in 14 cases of ALLEo are diverse, including rash,
purpura, ecchymosis, and one report of erythroderma.3 Eosino-
philia may antedate the development of ALL by several months
to 2 years, and patients may present features of HES during this
period.9 Eosinophilia resolves with remission and usually returns
with a relapse of the disease.10 The majority of cases of ALLEo
are of the B-cell type, and a few cases have been described of
T-cell ALLEo; B-cell ALLEo with myeloid antigen expression;
and biphenotypic (B-cell/T-cell) ALLEo.1,5,10 Granular ALL
confers a poor prognosis on children with ALL of the B-cell
precursor phenotype,11 and two cases of granular ALLEo have
been described.5,12 Cytogenetic abnormalities have been detected
in approximately half (30/52) of the patients with ALLEo.4 The
most common abnormality has been t(5;14)(q31;q32). This entity
is now included as “B-lymphoblastic leukemia/lymphoma with
t(5;14); IL-3-IGH” in the new World Health Organization clas-
sification of lymphoid neoplasms published in 2008. The present
case was a rare form of B-cell ALLEo with granular lympho-
blasts, myeloid antigen expression, and normal cytogenetic
testing. The present patient has remained in remission for 4 years,
and her symptoms, pulmonary infiltrates, and eosinophilia
responded quickly to induction chemotherapy.
Eosinophilia is considered to be reactive in ALLEo and results
from cytokine production by leukemic blasts (because chromo-
somal abnormality is usually found only in leukemic blasts); and
eosinophils have normal karyotypes in 90% of cases.4 In ALLEo
with t(5;14)(q31:q32), eosinophilia is secondary to overproduc-
tion of IL-3 by the blasts due to activation of the IL-3 gene on
chromosome 5 after its translocation, adjacent to the immuno-
globulin heavy chain gene on chromosome 14.8 In the present
patient, the level of IL-3 and IL-5 in the serum was significantly
elevated on admission and normalized with treatment. IL-3 and
IL-5 were likely to be produced by the lymphoblasts. The present
finding further supports the assumption that eosinophilia arises
due to cytokine production by leukemic blasts in patients with
ALLEo. We cannot, however, exclude the possibility that acti-
vated leukocytes including eosinophils produce a large amount of
cytokines. In addition, chemotherapy reduces normal hematopoi-
etic cells as well as leukemic cells.
The FIP1L1-PDGFRA fusion has been described in patients
with chronic eosinophilic leukemia, which can present as idio-
pathic HES. Recent report showed that the presence of the
FIP1L1-PDGFRA fusion gene was detected in five patients with
acute myeloid leukemia and associated eosinophilia.13 In these
cases, FIP1L1-PDGFRA-positive cells were seen in >90% of all
marrow cells, clearly indicating that blast cells were indeed
FIP1L1-PDGFRA positive. The presence of FIP1L1-PDGFRA
was confirmed in all these cases by amplification and sequencing
of the RNA fusion sequences on RT-PCR and of the genomic
DNA fusion sequences on long-template-PCR and bubble-PCR.
In the present case, we investigated the presence of FIP1L1-
PDGFRA mRNA in lymphoblasts in bone marrow, because this
fusion gene was reported in the blasts of acute myeloid leukemia.
In conclusion, we describe a rare form of granular B-cell
ALLEo with myeloid antigen expression. Eosinophilia disap-
peared along with the normalization of IL-3 and IL-5 in the
serum on chemotherapy; it further supports the reactive nature of
eosinophilia in ALLEo. FIP1L1-PDGFRA was negative, and
clinical response to chemotherapy was excellent with achieve-
ment of complete remission for 4 years. Hematologic malignancy
should be considered in every patient with hyper-eosinophilia,
before attributing it to HES.
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Atomoxetine improves communication in a girl with
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Abstract This report describes the case of an ADHD girl (hereafter referred to as K) with semantic-pragmatic disorder, she was
treated with atomoxetine. K was a 9-year-old girl. She had difficulty understanding words or sentences, finding words,
and producing sentences. K also displayed symptoms of severe inattentiveness. K was diagnosed with DSM-IV-defined1
ADHD, predominantly the inattentive type. Her communication impairment was considered symptomatic of semantic-
pragmatic disorder. K was started on atomoxetine, the dose was increased to 50 mg/day (dosage based on weight:
1.8 mg/kg). Her communication activities were improved a few weeks after atomoxetine 50 mg/day was administered.
She was unable to organize information pertaining to words, and so could not use words in expressive language. These
problems were mitigated through the administration of atomoxetine. Further prospective studies are needed to better
understand the therapeutic effects of atomoxetine in patients with semantic-pragmatic disorder.
Key words atomoxetine, attention-deficit hyperactivity disorder, executive function, semantic-pragmatic disorder.
Attention-deficit hyperactivity disorder (ADHD) is characterized
by behaviors of inattentiveness, hyperactivity and impulsivity.1
Neuropsychological impairments may accompany the behavioral
manifestations, and deficits in executive function are evident in
many children and adolescents with ADHD. Atomoxetine hydro-
chloride has been indicated for the treatment of ADHD. Cogni-
tion may be related to functional outcomes, and atomoxetine
improves attention and executive function as well as other cog-
nitive domains.2 Many children with ADHD have comorbid diag-
noses,3,4 and behavioral problems associated with ADHD are
related to pragmatic competence.5 Pragmatic difficulties involve
secondary consequences of specific language impairments, and
disproportionate pragmatic difficulties in mastering structural
aspects of language are termed semantic-pragmatic disorder.6
Some children with semantic-pragmatic disorder have limited
language structures, and the pragmatic difficulties may be
regarded as secondary to the structural language difficulties; in
others, phonology and syntax are unimpaired, and the pragmatic
difficulties may be regarded as an indication that the child has
autism or an autistic spectrum disorder. There may be many
intermediate cases.6 Children with semantic-pragmatic disorder
have greater difficulty in making conversation than the limita-
tions of language structure can explain. Semantic-pragmatic
disorder without impairment of phonology or syntax is charac-
terized by verbosity with comprehension deficits for connected
speech, word-finding deficits and atypical word choice frequent,
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